CN1029081C - Productive method for Chinese Cpd. medicine "Sang-ji-Dan" - Google Patents
Productive method for Chinese Cpd. medicine "Sang-ji-Dan" Download PDFInfo
- Publication number
- CN1029081C CN1029081C CN 88100254 CN88100254A CN1029081C CN 1029081 C CN1029081 C CN 1029081C CN 88100254 CN88100254 CN 88100254 CN 88100254 A CN88100254 A CN 88100254A CN 1029081 C CN1029081 C CN 1029081C
- Authority
- CN
- China
- Prior art keywords
- fine powder
- radix
- concentrated solution
- herba
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a method for producing a compound traditional Chinese medicine preparation for controlling hyperlipemia, arteriosclerosis and coronary diseases. Traditional Chinese medicines of parasitic loranthus, kudzuvine root, salvia miltiorrhiza, etc. are pulverized and sieved to prepare fine powder according to certain recipe proportion. Coarse grains are infiltrated by water, and are decocted and filtered into concentrated solution. Concentrated solution is adhered with fine powder to make small pills, and thus, Sang gedan pill is prepared. The preparation technology is stable, and the quality standard conforms to the specification of Chinese pharmacopoeia. The present invention has the advantages of high curative effect on controlling hyperlipemia, arteriosclerosis and coronary diseases, safety, reliability and no poisonous side effect.
Description
The invention belongs to a kind of production method of compound Chinese medicinal preparation.
Hyperlipemia is the pathological change that one or more dyslipidemias increase in the blood of human body, often can cause serious diseases such as atherosclerosis, coronary heart disease, hypertension.Therefore preventing and treating hyperlipemia becomes a domestic and international medical science urgency important topic to be solved.
At present both at home and abroad the blood lipid-lowering medicine that uses has clofibrate and derivant thereof, nicotinic acid, cholestyramine, fenofibrate, bezalip, sugared acid anhydride fat, Elastase, arteries and veins health, oryzanol, vitamin E, blood fat reducing equality, though certain curative effect is arranged, but toxic and side effects such as digestive tract discomfort, hepatic and renal function injure, leukocyte decline and bleeding tendency are arranged, and curative effect is not consolidated, and knock-on is arranged after the drug withdrawal.Clofibrate also can make cholelithiasis, pulmonary infarction, anginal increasing.The domestic extensive use of Chinese medicine blood fat reducing, folk prescription has Rhizoma Alismatis tablets of reducing blood fat, SHANZHAN JIANGZHI PIAN, Herba Taxilli electuary, artificial aweto, Radix Oenotherae erythrosepalae oil, Pollen Typhae, rhubarb powder, Hirudo powder, Radix Camelliae sinensis, Bulbus Allii quintessence oil, injection of Radix Bupleuri, royal jelly capsule, Herba bromi japonici, Semen phaseoli radiati powder, the former powder of Pleurotus ostreatus etc.; Compound recipe has JIANGZHILING, melt hat soup, flat fat is peaceful, fat reducing pill, compound antihyperglycemic sheet, hypogastric lipid-lowering pill etc.Above-mentioned Chinese medicine preparation, most curative effects are not high, without animal model experiment, lack the control of pharmacodynamics and toxicologic index and quality standard, need further investigate.
The object of the present invention is to provide knock-on and the not high weakness of above-mentioned Chinese medicine curative effect after a kind of toxic and side effects that can overcome above-mentioned Western medicine, the drug withdrawal, and have the production method of the Chinese medicine of preventing and treating hyperlipemia, arteriosclerosis, coronary heart disease of highly effective and safe.
Main points of the present invention are: it is standby that 120 mesh sieves were pulverized in 7 flavor medicines mixing such as Herba Taxilli, Radix Salviae Miltiorrhizae, Fructus Crataegi, Rhizoma Dioscoreae, Rhizoma Alismatis, Herba Taraxaci, Radix Et Rhizoma Rhei.It is standby that Flos Carthami was pulverized 120 mesh sieves separately.The above-mentioned 8 flavor coarse grain of medicines and Herba Artemisiae Scopariae, Radix Puerariae, Poria, the Radix Polygoni Multiflori decocted together to produce concentrated solution standby.Get above-mentioned 8 flavor medicine mixing fine powders and concentrated solution and put general ball jar pterygium in inner canthus ball.
The above-mentioned ratio of medicine in prescription of respectively distinguishing the flavor of is advisable in following scope: Herba Taxilli 10.23～17.04%, Radix Salviae Miltiorrhizae 10.23～17.04%, Fructus Crataegi 8.52～14.20%, Rhizoma Dioscoreae 6.82～11.36%, Herba Taraxaci 3.41～5.68%, Rhizoma Alismatis 5.11～8.52%, Radix Et Rhizoma Rhei 1.70～2.84%, Flos Carthami 5.11～8.52%, Herba Artemisiae Scopariae 3.41～5.68%, Radix Puerariae 10.23～17.04%, Poria 6.82～11.36%, the Radix Polygoni Multiflori 3.41～5.68%.
The preparation method of above-mentioned concentrated solution is: above-mentioned 8 flavor medicated powder are broken, cross the coarse grain behind 120 mesh sieves and Herba Artemisiae Scopariae, Radix Puerariae, Poria, the Radix Polygoni Multiflori of not pulverizing used water infiltration 1 hour together, decoct secondary, each 1 hour.Amount of water is 5～7 times of dose for the first time, is for the second time 4～6 times of dose.The filtrate of twice decoction is merged, and heating concentrates and forms.
The method of above-mentioned general ball is: whole fine powder mix homogeneously of getting 4/5ths and above-mentioned 7 flavor medicines of Flos Carthami fine powder.Earlier play mothers and sons with the bonding fine powder of an amount of concentrated solution, start general ball jar with the speed that per minute 100 changes, to mother and sons' spray liquid, be sprinkled into an amount of fine powder after making it evenly moistening with aerosol apparatus, treat that fine powder sticks to the mothers and sons surface equably, spray liquid is sprinkled into fine powder again.Like this repeatable operation, medicated powder has been spread till.The screening pill makes uniformity, with the ubiquitous pill skin of 1/5th Flos Carthami fine powders of remainder, and 60 ℃ of oven dry, shady and cool ventilation place drying is put in polishing, packing, airtight preservation.
The method of this general ball can also adopt the whole fine powder mix homogeneously of 8 flavor medicines, uses the method general ball identical with above-mentioned technology, and its curative effect is with aforesaid consistent, and just the end is a coat with the Flos Carthami fine powder, and is pleasing not as the former in appearance.
By formula proportion provided by the invention, also medicine can be made tablet, powder, electuary, or make injection through darker processing refinement.
The compound Chinese medicinal preparation that method provided by the invention is made has the following advantages:
1, the prescription composition is fixing, stable preparation process, and quality standard meets " Chinese pharmacopoeia regulation.
2, curative effect is higher, and is safe and reliable, has no side effect:
(1) the thousands of examples of treatment hyperlipemia, systematic observation 200 examples, cholesterol reducing effective percentage 92.6%, decline average 68mg/dl, rate of descent 22.5%; Triglyceride reducing effective percentage 91.3%, decline average 146mg/dl, rate of descent 39.4%; Beta Lipoprotein effective percentage 93.3% decline average 217mg/dl falls, rate of descent 28.8%.
(2) evident in efficacy to malignant hyperlipemia.Systematic observation 160 examples, curative effect is consistent with above-mentioned hyperlipemia.At present domestic and international rare report is to pernicious (severe) hyperlipemia curative effect medicine preferably.
(3) has the effect of high density lipoprotein increasing.Effective percentage 89.5%, rising average 20.2mg/dl, rate of rise 43.6%.Seldom report medicine at present both at home and abroad with this kind effect.
(4) late result is better.Follow up a case by regular visits to 50 examples, average withdrawal time 12.6 months, lipid determination compare zero difference (P＞0.05) when finishing with treatment, show efficacy consolidation.
(5) curative effect does not have regional disparity.To being distributed in 40 routine hyperlipemia clinical verifications of 10 provinces and cities such as Jilin, the Inner Mongol, Hebei, Henan, Anhui, Jiangsu, Guangdong, Sichuan, Yunnan and Beijing, curative effect is observed consistent with the court.
3, zoopery confirms that this medicine has the blood fat reducing speckle removing concurrently and removing thrombosis two acts on greatly, has pharmacodynamics, pathology and the hemorheology basis of atherosclerosis of preventing and treating and coronary heart disease.
4, the effect that has kidney and spleen invigorating, the fat-reducing that helps digestion, activating blood circulation to dissipate blood stasis, slow down aging is comparatively ideal compound Chinese medicinal preparation.
Embodiments of the invention:
Get Herba Taxilli 350 gram, Radix Salviae Miltiorrhizae 250 grams, Fructus Crataegi 300 grams, Rhizoma Dioscoreae 200 grams, Rhizoma Alismatis 150 grams, Herba Taraxaci 100 grams, Radix Et Rhizoma Rhei 40 grams, mix that to pulverize 120 mesh sieves standby.Getting Flos Carthami 160 gram, to pulverize 120 mesh sieves separately standby.The coarse grain of above-mentioned 8 flavor medicines is used water infiltration 1 hour with Radix Puerariae 300 grams, Herba Artemisiae Scopariae 120 grams, Poria 150 grams, the Radix Polygoni Multiflori 80 grams, decoct secondary.For the first time amount of water is 7 times of medication amount, decocts 1 hour, gets its filtrate; For the second time amount of water is 5 times of medication amount, decocts 1 hour, gets its filtrate; Twice filtrate is merged heating to be concentrated standby.The Flos Carthami fine powder of getting the above-mentioned 7 flavor whole fine powders of medicine and 4/5ths mixes, and is binding agent with above-mentioned concentrated solution, puts general ball in the general ball jar.On the basis of playing good mothers and sons, spraying liquid alternately repeats with the powder that spreads pesticides.General ball jar rotating speed is that per minute 100 changes.The screening pill makes uniformity, with the ubiquitous pill skin of 1/5th Flos Carthami fine powders of remainder, and 60 ℃ of oven dry, shady and cool ventilation place drying is put in polishing, packing, airtight preservation.
The foregoing description only selects for use Herba Taxilli, Radix Puerariae, Radix Salviae Miltiorrhizae, Fructus Crataegi, Rhizoma Alismatis, Herba Artemisiae Scopariae, Herba Taraxaci, Flos Carthami, Radix Et Rhizoma Rhei etc. 9 flavor medicines to make pill by preceding method, also rise similar curative effect.
Claims (3)
1, a kind of production method of preventing and treating the Chinese medicine of hyperlipemia disease is characterized in that:
A, with Herba Taxilli, Radix Salviae Miltiorrhizae, Fructus Crataegi, Rhizoma Dioscoreae, Rhizoma Alismatis, Herba Taraxaci, Radix Et Rhizoma Rhei mixing crushing screening, the independent crushing screening of Flos Carthami, the coarse grain of above-mentioned 8 flavor medicines and Herba Artemisiae Scopariae, Radix Puerariae, Poria, the Radix Polygoni Multiflori add water infiltration, decoction, filtration together, concentrate, the general ball of fine powder with the bonding aforementioned 8 flavor medicines of concentrated solution
B, the above-mentioned ratio of medicine in prescription of respectively distinguishing the flavor of are: Herba Taxilli 10.23～17.04%, Radix Salviae Miltiorrhizae 10.23～17.04%, Fructus Crataegi 8.52～14.20%, Rhizoma Dioscoreae 6.82～11.36%, Rhizoma Alismatis 5.11～8.52%, Herba Artemisiae Scopariae 3.41～5.68%, Herba Taraxaci 3.41～5.68%, Radix Et Rhizoma Rhei 1.70～2.84%, Flos Carthami 5.11～8.52%, Radix Puerariae 10.23～17.04%, Poria 6.82～11.36%, the Radix Polygoni Multiflori 3.41～5.68%.
2, press the production method of the described Chinese medicine of claim 1, the preparation that it is characterized in that concentrated solution is that aforementioned 8 flavor medicated powder is broken after sieving coarse grain and Herba Artemisiae Scopariae, Radix Puerariae, Poria, the Radixs Polygoni Multiflori were used water infiltration 1 hour together, decocts secondary, each 1 hour, merging filtrate, heating concentrates and forms.
3, by the production method of the described Chinese medicine of claim 1, it is characterized in that general ball is with the bonding fine powder of concentrated solution, in 4/5ths ubiquitous balls of Flos Carthami fine powder, / 5th ubiquitous balls are outer as coating, play earlier good mothers and sons, to mother and sons' spray liquid, make it evenly moistening after, be sprinkled into an amount of fine powder, treat that fine powder sticks to the mothers and sons surface equably, spray liquor is sprinkled into fine powder again, so alternately repeat, the general one-tenth of pill back is with 60 ℃ of oven dry.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 88100254 CN1029081C (en) | 1988-01-15 | 1988-01-15 | Productive method for Chinese Cpd. medicine "Sang-ji-Dan" |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 88100254 CN1029081C (en) | 1988-01-15 | 1988-01-15 | Productive method for Chinese Cpd. medicine "Sang-ji-Dan" |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1034136A CN1034136A (en) | 1989-07-26 |
| CN1029081C true CN1029081C (en) | 1995-06-28 |
Family
ID=4831272
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 88100254 Expired - Fee Related CN1029081C (en) | 1988-01-15 | 1988-01-15 | Productive method for Chinese Cpd. medicine "Sang-ji-Dan" |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1029081C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1070375C (en) * | 1997-09-15 | 2001-09-05 | 武汉博海生物工程有限公司 | Emulsion for lowering blood-lipid, and method for preparing same |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1050756C (en) * | 1994-06-16 | 2000-03-29 | 傅正和 | Viscosity-reducing and antithrombotic tablet and its producing technology |
| CN1055852C (en) * | 1996-12-18 | 2000-08-30 | 张继春 | Wine for reducing blood-pressure |
| CN1063649C (en) * | 1997-09-26 | 2001-03-28 | 操瑞明 | Red ginseng and hawthorn fruit health-care wine |
| CN1079253C (en) * | 1998-12-24 | 2002-02-20 | 赵徕淋 | Medicinal oil for dredging channels and collaterals of heart and brain and its preparing process |
| CN104042847A (en) * | 2014-07-03 | 2014-09-17 | 成都九芝堂金鼎药业有限公司 | Lipid-lowering pills for treating hyperlipidaemia and preparation method thereof |
| CN104383269A (en) * | 2014-12-08 | 2015-03-04 | 济南舜景医药科技有限公司 | Traditional Chinese medicine composition for treating coronary heart disease |
| CN104606462A (en) * | 2015-02-06 | 2015-05-13 | 刘延玲 | Medicine for conditioning alcoholic fatty liver and preparation method of medicine |
| CN104606461A (en) * | 2015-02-06 | 2015-05-13 | 刘延玲 | Lipid-lowering agent for non-alcoholic fatty liver and preparation method thereof |
| CN104606463A (en) * | 2015-02-06 | 2015-05-13 | 刘延玲 | Medicine for regulating moderate fatty liver and preparation method thereof |
-
1988
- 1988-01-15 CN CN 88100254 patent/CN1029081C/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1070375C (en) * | 1997-09-15 | 2001-09-05 | 武汉博海生物工程有限公司 | Emulsion for lowering blood-lipid, and method for preparing same |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1034136A (en) | 1989-07-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1330347C (en) | Gongbu ointment | |
| CN101411497B (en) | Lipid-lowering pressure-reducing hypoglycemic health tea | |
| CN105852127A (en) | Hypoglycemic hypolipidemic health-care product and production method | |
| CN103520577A (en) | Medicine-and-food dual-purpose preparation for treating pneumoconiosis, clearing away lung-heat and nourishing heart and preparation method for medicine-and-food dual-purpose preparation | |
| CN101274044A (en) | Medicament for preventing and treating fatty liver and method of preparing the same | |
| CN1029081C (en) | Productive method for Chinese Cpd. medicine "Sang-ji-Dan" | |
| CN101062339A (en) | Medicine for treating diabetes | |
| CN105918946A (en) | Red date and Chinese wolfberry fruit liver tonifying composition, granules and preparation method thereof | |
| CN104940485A (en) | Traditional Chinese medicine composition for treating infantile asthma and preparation method thereof | |
| CN101757312A (en) | Chinese medicine preparation for treating thrombocytopenia | |
| CN1046633C (en) | Compound melbine capsule and making process | |
| CN101249255B (en) | Proprietary Chinese medicine for curing children's cough and method of preparing the same | |
| CN106668631A (en) | Chinese herbal medicine for treating rhinitis | |
| CN104474195A (en) | Traditional Chinese medicine compound preparation for treating leucoderma and preparation method of traditional Chinese medicine compound preparation | |
| CN101757210A (en) | Veterinary drug composition for treating dysentery and preparation method thereof | |
| CN106334065A (en) | Edible and medicinal traditional Chinese medicine formula used for treating gynecological diseases and having beauty effect and production process | |
| CN105125838A (en) | Traditional Chinese medicine composite for treating infantile asthma and preparing method thereof | |
| CN101513504A (en) | Chinese herbal medicine for remedying thrombocytopenia after radiochemotherapy | |
| CN1422628A (en) | Baixue-Genzhi-Changshoubao-Chinese medicine for treating leukemia and concurrently treating aplastic anemia | |
| CN1194733C (en) | Medicine for treating hyperthyroidism and its prepn | |
| CN1241438A (en) | Lung cancer treating Chinese medicine preparation and its preparation | |
| CN1164318C (en) | Capsule for treating gynaecological inflammation | |
| CN1814125A (en) | Rehmannia-root preparation | |
| CN1073409C (en) | Method for preparing medicinal mask composition, and products thereby | |
| CN1061230C (en) | Process for preparing "Wujisan" granule |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |